Labeler
GlaxoSmithKline LLC NDC Codes
GlaxoSmithKline LLC lists 81 finished drug products in the FDA NDC Directory under NDC labeler codes 0173, 49401, 81864.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lamictal XR, Lamictal, Lamictal ODT, Imitrex, Jesduvroq, Ojjaara, Zejula, Breo Ellipta, Nucala, Arnuity Ellipta, Benlysta, Advair HFA, Wellbutrin SR, Advair Diskus, Trelegy Ellipta
- Active ingredients
- Lamotrigine, Fluticasone furoate, Salmeterol xinafoate, Vilanterol trifenatate, Fluticasone propionate, Sumatriptan succinate, Daprodustat, Umeclidinium bromide, Atovaquone, Momelotinib dihydrochloride monohydrate, Niraparib tosylate, Mepolizumab
- NDC labeler codes
- 0173, 49401, 81864
- Strengths
- Vilanterol trifenatate 25 ug/1; Umeclidinium bromide 62.5 ug/1; Lamotrigine 25 mg/1; Salmeterol xinafoate 50 ug/1; Fluticasone furoate 200 ug/1; Fluticasone furoate 100 ug/1; Lamotrigine 200 mg/1; Lamotrigine 100 mg/1; Salmeterol xinafoate 21 ug/1; Fluticasone furoate 50 ug/1; Mepolizumab 100 mg/mL; Lamotrigine 50 mg/1; Atovaquone 750 mg/5mL; Sumatriptan succinate 6 mg/.5mL; Depemokimab 100 mg/mL; Belantamab mafodotin 50 mg/mL; Gepotidacin mesylate 750 mg/1; Momelotinib dihydrochloride monohydrate 200 mg/1; Momelotinib dihydrochloride monohydrate 150 mg/1; Momelotinib dihydrochloride monohydrate 100 mg/1
- Dosage forms
- Tablet, Film coated, Powder, Kit, Tablet, Tablet, Film coated, Extended release, Injection, Tablet, Orally disintegrating, Aerosol, Metered, Injection, Solution, Tablet, For suspension, Injection, Powder, For solution, Injection, Powder, Lyophilized, For solution, Suspension, Solution, Aerosol, Powder, Powder, Metered
- Routes
- Oral, Respiratory (Inhalation), Subcutaneous, Intravenous
- Drug classes (FDA established)
- Anti-epileptic Agent, Mood Stabilizer, Corticosteroid, beta2-Adrenergic Agonist, Serotonin-1b and Serotonin-1d Receptor Agonist, Antimalarial, Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor, Anticholinergic, Antiprotozoal, Kinase Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor, Interleukin-5 Antagonist, B Lymphocyte Stimulator-specific Inhibitor, Aminoketone, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, Programmed Death Receptor-1 Blocking Antibody, Neuraminidase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 114
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Exdensurdepemokimab | Depemokimab 100 mg/mL | Injection, SolutionSubcutaneous | 0173-0927 | 00173-0927-4200173-0927-61 | — |
| Blenrepbelantamab mafodotin | Belantamab mafodotin 50 mg/mL | Injection, Powder, For solutionIntravenous | 0173-0913 | 00173-0913-01 | — |
| Blujepagepotidacin | Gepotidacin mesylate 750 mg/1 | Tablet, Film coatedOral | 0173-0922 | 00173-0922-3800173-0922-45 | — |
| Ojjaaramomelotinib | Momelotinib dihydrochloride monohydrate 200 mg/1 | TabletOral | 81864-101 | 81864-0101-30 | — |
| Ojjaaramomelotinib | Momelotinib dihydrochloride monohydrate 150 mg/1 | TabletOral | 81864-102 | 81864-0102-30 | — |
| Ojjaaramomelotinib | Momelotinib dihydrochloride monohydrate 100 mg/1 | TabletOral | 81864-103 | 81864-0103-30 | — |
| Zejulaniraparib | Niraparib tosylate 100 mg/1 | Tablet, Film coatedOral | 0173-0909 | 00173-0909-13 | — |
| Zejulaniraparib | Niraparib tosylate 200 mg/1 | Tablet, Film coatedOral | 0173-0912 | 00173-0912-1300173-0912-61 | — |
| Zejulaniraparib | Niraparib tosylate 300 mg/1 | Tablet, Film coatedOral | 0173-0915 | 00173-0915-1300173-0915-61 | — |
| Breo Elliptafluticasone furoate and vilanterol trifenatate | Fluticasone furoate 50 ug/1; Vilanterol trifenatate 25 ug/1 | PowderRespiratory (Inhalation) | 0173-0916 | 00173-0916-10 | — |
| Jesduvroqdaprodustat | Daprodustat 1 mg/1 | Tablet, Film coatedOral | 0173-0897 | 00173-0897-13 | — |
| Jesduvroqdaprodustat | Daprodustat 2 mg/1 | Tablet, Film coatedOral | 0173-0903 | 00173-0903-13 | — |
| Jesduvroqdaprodustat | Daprodustat 4 mg/1 | Tablet, Film coatedOral | 0173-0906 | 00173-0906-13 | — |
| Jesduvroqdaprodustat | Daprodustat 6 mg/1 | Tablet, Film coatedOral | 0173-0911 | 00173-0911-13 | — |
| Jesduvroqdaprodustat | Daprodustat 8 mg/1 | Tablet, Film coatedOral | 0173-0914 | 00173-0914-13 | — |
| Nucalamepolizumab | Mepolizumab 40 mg/.4mL | Injection, SolutionSubcutaneous | 0173-0904 | 00173-0904-42 | — |
| Jemperlidostarlimab | Dostarlimab 50 mg/mL | InjectionIntravenous | 0173-0898 | 00173-0898-03 | — |
| Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate | Fluticasone furoate 200 ug/1 + 2 more ingredients | PowderRespiratory (Inhalation) | 0173-0893 | 00173-0893-1000173-0893-1400173-0893-61 | — |
| Nucalamepolizumab | Mepolizumab 100 mg/mL | Injection, SolutionSubcutaneous | 0173-0892 | 00173-0892-0100173-0892-4200173-0892-61+1 more | — |
| Krintafeltafenoquine succinate | Tafenoquine succinate 150 mg/1 | Tablet, Film coatedOral | 0173-0889 | 00173-0889-39 | — |
| Arnuity Elliptafluticasone furoate | Fluticasone furoate 50 ug/1 | PowderRespiratory (Inhalation) | 0173-0888 | 00173-0888-10 | — |
| Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate | Fluticasone furoate 100 ug/1 + 2 more ingredients | PowderRespiratory (Inhalation) | 0173-0887 | 00173-0887-1000173-0887-1400173-0887-61 | — |
| Benlystabelimumab | Belimumab 200 mg/mL | SolutionSubcutaneous | 49401-088 | 49401-0088-0249401-0088-3549401-0088-47+2 more | — |
| Nucalamepolizumab | Mepolizumab 100 mg/mL | Injection, Powder, For solutionSubcutaneous | 0173-0881 | 00173-0881-0100173-0881-61 | — |
| Breo Elliptafluticasone furoate and vilanterol trifenatate | Fluticasone furoate 200 ug/1; Vilanterol trifenatate 25 ug/1 | PowderRespiratory (Inhalation) | 0173-0882 | 00173-0882-1000173-0882-14 | — |
| Arnuity Elliptafluticasone furoate | Fluticasone furoate 100 ug/1 | PowderRespiratory (Inhalation) | 0173-0874 | 00173-0874-1000173-0874-14 | — |
| Arnuity Elliptafluticasone furoate | Fluticasone furoate 200 ug/1 | PowderRespiratory (Inhalation) | 0173-0876 | 00173-0876-1000173-0876-14 | — |
| Incruse Elliptaumeclidinium | Umeclidinium bromide 62.5 ug/1 | Aerosol, PowderOral | 0173-0873 | 00173-0873-0600173-0873-10 | — |
| Anoro Elliptaumeclidinium bromide and vilanterol trifenatate | Umeclidinium bromide 62.5 ug/1; Vilanterol trifenatate 25 ug/1 | PowderRespiratory (Inhalation) | 0173-0869 | 00173-0869-0600173-0869-10 | — |
| Breo Elliptafluticasone furoate and vilanterol trifenatate | Fluticasone furoate 100 ug/1; Vilanterol trifenatate 25 ug/1 | PowderRespiratory (Inhalation) | 0173-0859 | 00173-0859-1000173-0859-14 | — |
| Lamictal XRlamotrigine | Lamotrigine 250 mg/1 | Tablet, Film coated, Extended releaseOral | 0173-0781 | 00173-0781-00 | — |
| Lamictal XRlamotrigine | Lamotrigine 300 mg/1 | Tablet, Film coated, Extended releaseOral | 0173-0761 | 00173-0761-00 | — |
| Benlystabelimumab | Belimumab 120 mg/1.5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 49401-101 | 49401-0101-01 | — |
| Benlystabelimumab | Belimumab 400 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 49401-102 | 49401-0102-01 | — |
| Lamictal XRlamotrigine | Lamotrigine 200 mg/1 | Tablet, Film coated, Extended releaseOral | 0173-0757 | 00173-0757-00 | — |
| Lamictal XRlamotrigine | — | Kit | 0173-0758 | 00173-0758-00 | — |
| Lamictal XRlamotrigine | — | Kit | 0173-0759 | 00173-0759-00 | — |
| Lamictal XRlamotrigine | — | Kit | 0173-0760 | 00173-0760-00 | — |
| Lamictal XRlamotrigine | Lamotrigine 25 mg/1 | Tablet, Film coated, Extended releaseOral | 0173-0754 | 00173-0754-00 | — |
| Lamictal XRlamotrigine | Lamotrigine 50 mg/1 | Tablet, Film coated, Extended releaseOral | 0173-0755 | 00173-0755-00 | — |
| Lamictal XRlamotrigine | Lamotrigine 100 mg/1 | Tablet, Film coated, Extended releaseOral | 0173-0756 | 00173-0756-00 | — |
| Lamictal ODTlamotrigine | Lamotrigine 25 mg/1 | Tablet, Orally disintegratingOral | 0173-0772 | 00173-0772-02 | — |
| Lamictal ODTlamotrigine | Lamotrigine 50 mg/1 | Tablet, Orally disintegratingOral | 0173-0774 | 00173-0774-02 | — |
| Lamictal ODTlamotrigine | Lamotrigine 100 mg/1 | Tablet, Orally disintegratingOral | 0173-0776 | 00173-0776-02 | — |
| Lamictal ODTlamotrigine | Lamotrigine 200 mg/1 | Tablet, Orally disintegratingOral | 0173-0777 | 00173-0777-02 | — |
| Lamictal ODTlamotrigine | — | Kit | 0173-0778 | 00173-0778-00 | — |
| Lamictal ODTlamotrigine | — | Kit | 0173-0779 | 00173-0779-00 | — |
| Lamictal ODTlamotrigine | — | Kit | 0173-0780 | 00173-0780-00 | — |
| Advair HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 230 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | 0173-0717 | 00173-0717-2000173-0717-22 | — |
| Advair HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 45 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | 0173-0715 | 00173-0715-2000173-0715-22 | — |
GlaxoSmithKline LLC: common questions
- What is GlaxoSmithKline LLC's NDC labeler code?
- 0173, 49401, 81864. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for GlaxoSmithKline LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.